SCHEMBL7504471

SCHEMBL7504471

COc1ccc2[nH]c(C(C)C3CCCNC3)c(-c3cncc(-c4ccc(Cl)cc4)c3)c2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 2/20 0.35
TLR9 Q9NR96 1/20 0.35
TLR8 Q9NR97 1/20 0.35
TLR7 Q9NYK1 1/20 0.35
CHRNA4 P43681 1/20 0.35
EIF2AK2 P19525 2/20 0.35
KDR P35968 1/20 0.35
MAP2 P11137 1/20 0.34
CHEK1 O14757 1/20 0.34
AURKA O14965 1/20 0.34
PRKD3 O94806 1/20 0.34
PRKCG P05129 1/20 0.34
PRKCB P05771 1/20 0.34
PRKCA P17252 1/20 0.34
CCNA2 P20248 1/20 0.34
PRKCH P24723 1/20 0.34
CDK2 P24941 1/20 0.34
PRKCI P41743 1/20 0.34
PRKCE Q02156 1/20 0.34
PRKCQ Q04759 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7509290 0.95 MAP2 (0.39) CHRNB2TLR9TLR8TLR7CHRNA4
SCHEMBL7508685 0.91 CYP11B1 (0.40) TLR9TLR8TLR7EIF2AK2KDR
SCHEMBL7502243 0.91 MAPK13 (0.38) CHRNB2TLR9TLR8TLR7CHRNA4
SCHEMBL7515481 0.90 CYP19A1 (0.37) CHRNB2CHRNA4CHEK1TGFBR1CHRNB1
SCHEMBL7513797 0.89 CHRM4 (0.37) CHRNB2CHRNA4CHEK1CHRM4DRD2
SCHEMBL7508483 0.87 CDK7 (0.37) TLR9TLR8TLR7CHEK1CHRM4
SCHEMBL7508903 0.87 CDK7 (0.41) CHRNB2TLR9TLR8TLR7CHRNA4
SCHEMBL7511117 0.87 CHEK1 (0.39) CHRNB2TLR9TLR8TLR7CHEK1
SCHEMBL7513926 0.87 PRKCZ (0.40) EIF2AK2KDRPRKCZHTR1DHTR1B
SCHEMBL7507532 0.86 CCNK (0.36) MAP2CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP claimed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP claimed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO claimed
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP disclosed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP disclosed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO disclosed